Skip to content

Effect of Diets on the Gut Microbiota Composition and Cardiometabolic Wellbeing

The Effect of Pork and Chicken Diets on Gut Microbiota Composition and Metabolites Related to Cardiometabolic Wellbeing

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03539666
Enrollment
38
Registered
2018-05-29
Start date
2018-07-27
Completion date
2019-04-16
Last updated
2026-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

The project will characterize human gut microbiome response to two different diets and the possible physiological and biochemical implications of such response on cardiometabolic risk factors. The study will use controlled-feeding, systems-biology, metagenomic, and metabolomic approaches to examine American dietary patterns.

Detailed description

The study will use controlled-feeding, systems-biology, metagenomic, and metabolomic approaches to examine American dietary patterns.

Interventions

OTHERdiet

dietary patterns

Sponsors

South Dakota State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* generally good health status based on one routine physical in the past 15 months, current health status * normal HbA1C, weigh 110 lb or more * Age 50 years or more, generally healthy, all races and both sexes * generally practicing a meat-based dietary pattern, do not have any special dietary requirement, and * willingness to comply with the study protocol, including on-site meal consumption and sample/data collection.

Exclusion criteria

* medication usage, probiotic, long-term antibiotic, and tobacco/drug/alcohol use * Not on any special diet within 3 months of recruitment, and do not have any intention to lose weight. * impaired kidney functions * Active history of cancer, diabetes, heart, liver, and kidney diseases * major gastrointestinal disorders in the past 3 months * history of heart attacks or stroke * Unable to meet in-person visit requirements for dining, picking up meals, and tests * Any mental health condition that would affect the ability to provide written informed consent. * If they had not had a routine health checkup during the 12 months prior to recruitment. * If they were unwilling to abstain from taking nutritional supplements, alcohol, non-study foods, and beverage during the study period.

Design outcomes

Primary

MeasureTime frameDescription
Microbiota-dependent TMAO-response, measured as serum concentration10 days per diet armtargeted sequencing
Serum concentration of biogenic amine metabolites10 days per diet armMetabolomics

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORMoul Dey, Ph.D

South Dakota State University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 16, 2026